In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS

Metallomics

Volumn 5, Issue 6, 2013, Pages 636-647

  Hermann, Gerrit ^a   Heffeter, Petra ^b   Falta, Thomas ^a   Berger, Walter ^b   Hann, Stephan ^a   Koellensperger, Gunda ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE MEDIUMS; CENTRIFUGAL FILTRATION; CONTINUOUS EXPOSURE; HIGH MOLECULAR WEIGHT; INTRACELLULAR CONCENTRATION; INTRACELLULAR DISTRIBUTION; LOW MOLECULAR WEIGHT; PSEUDO FIRST-ORDER KINETICS;

CELL CULTURE; CELLS; CENTRIFUGATION; EXPERIMENTS; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; KINETICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETERS; MOLECULAR WEIGHT; PLATINUM; TUMORS;

PLATINUM COMPOUNDS;

CELL EXTRACT; CISPLATIN; SODIUM CHLORIDE;

ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CELL VOLUME; COLON CARCINOMA; CYTOSOL; DRUG ACCUMULATION; DRUG DEGRADATION; DRUG HALF LIFE; FILTRATION; HUMAN; IN VITRO STUDY; KINETICS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MESOTHELIOMA; MOLECULAR WEIGHT; PRIORITY JOURNAL;

CHROMATOGRAPHY, LIQUID; CISPLATIN; HCT116 CELLS; HUMANS; MASS SPECTROMETRY; NEOPLASMS;

EID: 84878808036     PISSN: 17565901     EISSN: 1756591X     Source Type: Journal    
DOI: 10.1039/c3mt20251h     Document Type: Article

References (57)

1. B. Rosenberg L. Vancamp T. Krigans Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode Nature 1965 205 698 699
2. B. Rosenberg L. Vancamp J. E. Trosko V. H. Mansour Platinum compounds: A new class of potent antitumour agents Nature 1969 222 385 386
3. F. Muggia Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancer Gynecol. Oncol. 2009 112 1 275 281
4. T. Boulikas M. Vougiouka Cisplatin and platinum drugs at the molecular level. (Review). Oncol. Rep. 2003 10 6 1663 1682
5. L. H. Einhorn Curing metastatic testicular cancer Proc. Natl. Acad. Sci. U. S. A. 2002 99 7 4592 4595
6. L. Kelland The resurgence of platinum-based cancer chemotherapy Nat. Rev. Cancer 2007 7 8 573 584
7. S. Hann G. Koellensperger Zs. Stefánka G. Stingeder M. Fürhacker W. Buchberger R. M. Mader Application of HPLC-ICP-MS to speciation of cisplatin and its degradation products in water containing different chloride concentrations and in human urine J. Anal. At. Spectrom. 2003 18 1391 1395
8. E. R. Jamieson S. J. Lippard Structure, recognition, and processing of cisplatin-DNA adducts Chem. Rev. 1999 99 9 2467 2498
9. 2) + (XCl, OH) with glycine, monohydrogen malonate and chloride Inorg. Chim. Acta 1991 187 2 125 132
10. S. F. Bellon J. H. Coleman S. J. Lippard DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis- diamminedichloroplatinum(ii) Biochemistry 1991 30 32 8026 8035
11. C. Demarcq R. T. Bunch D. Creswell A. Eastman The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells Cell Growth Differ. 1994 5 9 983 993
12. E. Lindauer E. Holler Cellular distribution and cellular reactivity of platinum(ii) complexes Biochem. Pharmacol. 1996 52 1 7 14
13. L. A. Zwelling T. Anderson K. W. Kohn DNA-protein and DNA interstrand cross-linking by cis- and transplatinum(ii) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity Cancer Res. 1979 39 2 I 365 369
14. V. Cepeda M. A. Fuertes J. Castilla C. Alonso C. Quevedo J. M. Pérez Biochemical mechanisms of cisplatin cytotoxicity Anti-Cancer Agents Med. Chem. 2007 7 1 3 18
15. C. F. Harrington R. C. Le Pla G. D. D. Jones A. L. Thomas P. B. Farmer Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry Chem. Res. Toxicol. 2010 23 8 1313 1321
16. D. Gibson The mechanism of action of platinum anticancer agents-What do we really know about it? Dalton Trans. 2009 10681 10689
17. Y. Kasherman S. Sturup D. Gibson Is glutathione the major cellular target of cisplatin? A study of the interactions of cisplatin with cancer cell extracts J. Med. Chem. 2009 52 14 4319 4328
18. J. Reedijk and J. M. Teuben, Platinum-Sulfur Interactions Involved in Antitumor Drugs, Rescue Agents, and Biomolecules, Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug, ed., B. Lippert, 1999, pp. 339-362
19. D. Garmann A. Warnecke G. V. Kalayda F. Kratz U. Jaehde Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells J. Controlled Release 2008 131 2 100 106
20. H. M. Yu T. C. Wang Mechanism of cisplatin resistance in human urothelial carcinoma cells Food Chem. Toxicol. 2012 50 5 1226 1237
21. T. Falta P. Heffeter A. Mohamed W. Berger S. Hann G. Koellensperger Quantitative determination of intact free cisplatin in cell models by LC-ICP-MS J. Anal. At. Spectrom. 2011 26 1 109 115
22. B. Gammelgaard H. R. Hansen S. Stürup C. Møller The use of inductively coupled plasma mass spectrometry as a detector in drug metabolism studies Expert Opin. Drug Metab. Toxicol. 2008 4 9 1187
23. T. Shoeib B. L. Sharp Interactions of oxaliplatin with the cytoplasmic thiol containing ligand glutathione Metallomics 2012 4 12 1308 1320
24. B. Michalke Platinum speciation used for elucidating activation or inhibition of Pt-containing anti-cancer drugs J. Trace Elem. Med. Biol. 2002 24 2 69 77
25. D. E. Fernández E. Moreno-Gordaliza B. Cañas M. A. Palacios M. M. Gómez-Gómez Analytical methodologies for metallomics studies of antitumor Pt-containing drugs Metallomics 2010 2 19 38
26. D. Esteban-Fernández B. Cañas I. Pizarro M. A. Palacios M. M. Gómez-Gómez SEC-ICP-MS and ESI-MS as tools to study the interaction between cisplatin and cytosolic biomolecules J. Anal. At. Spectrom. 2007 22 9 1113 1121
27. M. Cui Z. Mester Electrospray ionization mass spectrometry coupled to liquid chromatography for detection of cisplatin and its hydrated complexes Rapid Commun. Mass Spectrom. 2003 17 14 1517 1527
28. M. El-Khateeb T. G. Appleton B. G. Charles L. R. Gahan Development of HPLC conditions for valid determination of hydrolysis products of cisplatin J. Pharm. Sci. 1999 88 3 319 326
29. S. Hann T. Falta K. Boeck M. Sulyok G. Koellensperger On-line fast column switching SEC × IC separation combined with ICP-MS detection for mapping metallodrug-biomolecule interaction J. Anal. At. Spectrom. 2010 25 861 866
30. S. Hann K. Boeck G. Koellensperger Immunoaffinity assisted LC-ICP-MS-a versatile tool in biomedical research J. Anal. At. Spectrom. 2010 25 18 20
31. M. Sulyok S. Hann C. Hartinger B. K. Keppler G. Stingeder G. Koellensperger Two dimensional separation schemes for investigation of the interaction of an anticancer ruthenium(iii) compound with plasma proteins J. Anal. At. Spectrom. 2005 9 856 863
32. P. Heffeter K. Böck B. Atil M. A. R. Hoda W. Körner C. Bartel U. Jungwirth B. Keppler M. Micksche W. Berger G. Koellensperger Intracellular protein binding pattern of the anticancer ruthenium drugs KP1019 and KP1339 J. Biol. Inorg. Chem. 2010 15 5 737 748
33. G. Koellensperger S. Hann Ultra-fast HPLC-ICP-MS analysis of oxaliplatin in patient urine Anal. Bioanal. Chem. 2010 397 1 401 406
34. T. Falta G. Koellensperger A. Standler W. Buchberger R. M. Mader S. Hann Quantification of cisplatin, carboplatin and oxaliplatin in spiked human plasma samples by ICP-SFMS and hydrophilic interaction liquid chromatography (HILIC) combined with ICP-MS detection J. Anal. At. Spectrom. 2009 24 1336
35. G. Koellensperger K. Meelich M. Galanski Zs. Stefanka G. Stingeder S. Hann Species specific IDMS for the quantification of carboplatin in urine by LC-ICP-MS and LC-ESI-MS J. Anal. At. Spectrom. 2008 23 29 36
36. M. F. Mesko C. A. Hartwig C. A. Bizzi J. S. F. Pereira P. A. Mello E. M. M. Flores Sample preparation strategies for bioinorganic analysis by inductively coupled plasma mass spectrometry Int. J. Mass Spectrom. 2011 307 1-3 123 136
37. M. Q. T. Tran Y. Nygren C. Lundin P. Naredi E. Björn Evaluation of cell lysis methods for platinum metallomic studies of human malignant cells Anal. Biochem. 2010 396 1 6 82
38. A. Ghezzi M. Aceto C. Cassino E. Gabano D. Osella Uptake of antitumor platinum(ii)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS) J. Inorg. Biochem. 2004 98 1 73 78
39. R. G. Pearson Hard and soft acids and bases, HSAB, part I: Fundamental principles J. Chem. Educ. 1968 45 9 581 587
40. R. G. Pearson Hard and soft acids and bases, HSAB, Part II: Underlying theories J. Chem. Educ. 1968 45 10 643 648
41. K. Kudoh Y. Kikuchi J. Hirata T. Kita H. Hiramatsu T. Tode I. Nagata A role of glutathione in resistance mechanisms to cis-diamminedichloroplatinum(ii) in human ovarian cancer cell lines in vitro Oncol. Rep. 1995 2 5 763 768
42. A. K. Godwin A. Meister P. J. O'Dwyer C. S. Huang T. C. Hamilton M. E. Anderson High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis Proc. Natl. Acad. Sci. U. S. A. 1992 89 7 3070 3074
43. P. Mistry L. R. Kelland G. Abel S. Sidhar K. R. Harrap The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines Br. J. Cancer 1991 64 2 215 220
44. P. A. Andrews M. P. Murphy S. B. Howell Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion Cancer Res. 1985 45 12 6250 6253
45. T. C. Hamilton M. A. Winker K. G. Louie Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion Biochem. Pharmacol. 1985 34 14 2583 2586
46. A. D. Lewis J. D. Hayes C. R. Wolf Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: Intrinsic differences and cell cycle effects Carcinogenesis 1988 9 7 1283 1287
47. V. Janson B. Andersson P. Behnam-Motlagh K. G. Engstrom R. Henriksson K. Grankvist Cell. Physiol. Biochem. 2008 22 45 56
48. C. Haberhauer-Troyer M. Delic B. Gasser D. Mattanovich S. Hann G. Koellensperger Accurate quantification of the redox sensitive GSH/GSSG ratios in the yeast Pichia pastoris by HILIC-MS/MS Anal. Bioanal. Chem. 2013 405 6 2031 2039
49. S. Hann Zs. Stefánka K. Lenz G. Stingeder Anal. Bioanal. Chem. 2005 381 405 412
50. T. G. Appleton J. R. Hall S. F. Ralph C. S. M. Thompson NMR study of acid-base equilibria and other reactions of ammineplatinum complexes with aqua and hydroxo ligands Inorg. Chem. 1989 28 10 1989 1993
51. S. E. Miller D. A. House The hydrolysis products of cis- diamminedichloroplatinum(ii). I. The kinetics of formation and anation of the cis-diammine(aqua)chloroplatinum(ii) cation in acidic aqueous solution Inorg. Chim. Acta 1989 161 1 131 137
52. S. E. Miller D. A. House The hydrolysis products of cis- dichlorodiammineplatinum(ii) 2. The kinetics of formation and anation of the cis-diamminedi(aqua)platinum(ii) cation Inorg. Chim. Acta 1989 166 2 189 197
53. M. S. Davies S. J. Berners-Price T. W. Hambley Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: Improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA Inorg. Chem. 2000 39 25 5603 5613
54. 2 = en, tn) Inorg. Chim. Acta 1997 257 1 11 18
55. Z. Stefánka S. Hann G. Koellensperger G. Stingeder Investigation of the reaction of cisplatin with methionine in aqueous media using HPLC-ICP-DRCMS J. Anal. At. Spectrom. 2004 19 7 894 898
56. J. C. Dabrowiak J. Goodisman A. K. Souid Kinetic study of the reaction of cisplatin with thiols Drug Metab. Dispos. 2002 30 12 1378 1384
57. S. C. Mann P. A. Andrews S. B. Howell Short-term cis diamminedichloroplatinum(ii) accumulation in sensitive and resistant human ovarian carcinoma cells Cancer Chemother. Pharmacol. 1990 25 4 236 240